Showing 1 - 2 results of 2 for search 'Idoia Morilla', query time: 0.01s Refine Results
  1. 1
    Functional systemic CD4 immunity is required for clinical responses to PD‐L1/PD‐1 blockade therapy

    Functional systemic CD4 immunity is required for clinical responses to PD‐L1/PD‐1 blockade therapy by Miren Zuazo, Hugo Arasanz, Gonzalo Fernández‐Hinojal, Maria Jesus García‐Granda, María Gato, Ana Bocanegra, Maite Martínez, Berta Hernández, Lucía Teijeira, Idoia Morilla, Maria Jose Lecumberri, Angela Fernández de Lascoiti, Ruth Vera, Grazyna Kochan, David Escors

    Published 2019-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Denosumab as an immune modulator in HER2-negative early breast cancer: results of the window-of-opportunity D-BIOMARK clinical trial

    Denosumab as an immune modulator in HER2-negative early breast cancer: results of the window-of-opportunity D-BIOMARK clinical trial by Andrea Vethencourt, Eva M. Trinidad, Eduard Dorca, Anna Petit, M. Teresa Soler-Monsó, Marina Ciscar, Alexandra Barranco, Gema Pérez-Chacón, María Jimenez, Mario Rodríguez, Clara Gomez-Aleza, Elvira Purqueras, Enrique Hernández-Jiménez, Ander Urruticoechea, Idoia Morilla, Isaac Subirana, Amparo García-Tejedor, Miguel Gil-Gil, Sonia Pernas, Catalina Falo, Eva Gonzalez-Suarez

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: